If you had paused on Calumet back on 1 January 2026, the split between bullish and bearish analyst targets already forced a hard choice. For Calumet shareholders, the return from the start of the year was 152.2%, including dividends. That kind of move turns a quiet refinery and renewables debate into an urgent postmortem. If you were weighing those 2025 forecasts, what mattered more: aggressive MaxSAF expansion plans or warnings about high debt and regulatory risk?
The useful thing about a Narrative is that the reasoning is checkable: the assumptions sit beside the argument, and together they imply an estimated Fair Value you can disagree with.
The easy part of this move is behind Calumet. Zero in on 29 high quality undervalued stocks for companies trading below our estimates.
Calumet shares cost US$19.87 at the start of the period, and investors were pulled between two sharply different stories about what came next.
The bullish narrative put fair value at US$33, built on the idea that revenue could grow 12.5% a year and that renewables would support a profit margin moving toward 14.9% over a 3 year horizon.
The cautious view anchored fair value at US$13.25 and focused on regulatory volatility, with revenue growth of 6.5% and concern that changing rules around renewable diesel and SAF credits could restrict earnings power.
Calumet’s Q2 2026 report gave the bullish side fresh support. Revenue reached US$1.45b compared with US$1.03b a year earlier, and the loss narrowed from US$147.9m to US$95.9m as net margin moved from -14.4% to -6.6%. Profitability was still absent, so the optimistic earnings journey remained unproven. Overall, the evidence cut both ways.
The key assumption investors priced was whether MaxSAF growth would translate into actual earnings. For any other refiner with big transition plans, it may be useful to track the combination of reported net income and margin, not just project milestones or capacity headlines.
Calumet trades at US$49.3 today after a 152.2% gain from the start of the year. The selected Narrative places its Fair Value below that level and frames the recent funding moves as helpful but not enough to remove pressure from regulation, financing costs, and long-term demand shifts.
A buyer at today’s price is effectively assuming Montana Renewables delivers sustained, healthy margins. The key question is how that assumption compares with the Narrative’s concern about tougher policy settings and higher capital costs.
"Despite Calumet's continued cost reductions in its Montana Renewables segment, the business remains acutely exposed to volatility in regulatory policies around renewable diesel, SAF, and related tax credits. Protracted regulatory uncertainty, such as delays or tightening of RVO mandates, could precipitate sustained low industry margins, significantly reducing earnings and EBITDA from this unit."
One Narrative has put a figure on that disagreement. → See the Narrative with its lower Fair Value, assumptions and all
Once you understand Calumet, it is natural to look one layer back. Refineries and renewables projects still depend on reliable movement of fuel.
Your question then shifts. Who quietly handles the long-distance transport, storage and export work that keeps molecules flowing?
One large operator focuses on natural gas, liquids and crude pipelines, plus storage and export terminals. Its assets help power plants, data centers and fuel buyers secure steady supply.
The more infrastructure customers sign long-term contracts, the more that network can matter. For someone studying Calumet today, that parallel story may be worth a closer look.
One Narrative has already put a figure on it. → Uncover the company trading 16% below one Narrative's Fair Value
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com